Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Paolo Strati"'
Autor:
Gohar S. Manzar, Elaine E. Cha, Kelsey L. Corrigan, Alison K. Yoder, Benjamin R. Schrank, Lewis F. Nasr, Dai Chihara, Luis Malpica Castillo, Ranjit Nair, Preetesh Jain, Sattva S. Neelapu, Maria A. Rodriguez, Paolo Strati, Loretta J. Nastoupil, Jillian R. Gunther, Bouthaina S. Dabaja, Chelsea C. Pinnix, Susan Y. Wu, Penny Q. Fang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundDiffuse large B-cell lymphoma (DLBCL) involving the gastrointestinal (GI) organs is rare, and real-world outcomes after combined modality therapy (CMT) with systemic therapy (ST) and radiotherapy (RT) are not well-characterized, particularl
Externí odkaz:
https://doaj.org/article/df84bc152914455598065c60f0d5222a
Autor:
Penny Fang, MD, MBA, Sonal S. Noticewala, MD, Susan Y. Wu, MD, Jillian R. Gunther, MD, PhD, Ethan B. Ludmir, MD, L. Jeffrey Medeiros, MD, Paolo Strati, MD, Ranjit Nair, MD, Chijioke Nze, MD, Loretta J. Nastoupil, MD, Sairah Ahmed, MD, Luis Malpica Castillo, MD, Luis Fayad, MD, Jason Westin, MD, Sattva Neelapu, MD, Christopher Flowers, MD, Auris Huen, MD, Swaminathan P. Iyer, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101650- (2024)
Purpose: Extranodal NK/T-cell lymphoma (ENKTCL) is rare in the Western Hemisphere and is commonly treated with combined modality therapy (CMT). Methods and Materials: We retrospectively reviewed 35 patients treated with Ann Arbor stage I/II ENKTCL be
Externí odkaz:
https://doaj.org/article/1b79041406a44fdbaeef87666f666797
Autor:
Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ahmed Fetooh, MBBS, Gohar S. Manzar, MD, PhD, Kelsey L. Corrigan, MD, MPH, Benjamin R. Schrank, MD, PhD, Lewis Nasr, MD, MS, Dai Chihara, MD, PhD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Preetesh Jain, MBBS, MD, DM, PhD, Sattva S. Neelapu, MD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD, PhD, Jillian R. Gunther, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101648- (2024)
Purpose: Definitive intent radiation therapy (RT) for early-stage mucosa-associated lymphoid tissue (MALT) lymphoma typically includes a dose of 24 to 30 Gy. While modest, these doses may have associated toxicity. For patients with indolent B-cell ly
Externí odkaz:
https://doaj.org/article/8e49e699e2d345d8915aa234f82ed81f
Autor:
Ashwath Gurumurthi, Collin K. Chin, Lei Feng, Nathan H. Fowler, Paolo Strati, Fredrick B. Hagemeister, Luis E. Fayad, Jason R. Westin, Chizobam Obi, Janine Arafat, Ranjit Nair, Raphael E. Steiner, Sattva S. Neelapu, Christopher R. Flowers, Loretta J. Nastoupil
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102747- (2024)
Summary: Background: Rituximab and lenalidomide is a preferred option for relapsed indolent B cell non-Hodgkin lymphoma. Obinutuzumab may be a superior combination partner with lenalidomide given enhanced antibody dependent cellular cytotoxicity and
Externí odkaz:
https://doaj.org/article/ce025c6f41e44776b07e12e8ef403353
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/a0b9f803259b4ee2b51ed2dfc0427697
Autor:
Raphael E. Steiner, Edwin R. Parra, Francisco Vega, Lei Feng, Jason R. Westin, Sattva S. Neelapu, Paolo Strati, Michael R. Green, Christopher R. Flowers, Luisa M. Solis, Ignacio I. Wistuba, Sairah Ahmed, Ranjit Nair, Fredrick B. Hagemeister, Mansoor Noorani, Mario L. Marques-Piubelli
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-5 (2023)
Abstract Primary mediastinal (thymic) large B-cell lymphoma (PMBCL) is a rare, aggressive subtype of non-Hodgkin lymphoma and has a complex inflammatory microenvironment. Although most patients can be cured with standard-of-care immunochemotherapy, p
Externí odkaz:
https://doaj.org/article/e3114eba62f94495bc871889c61eb0f9
Autor:
Andrew P. Jallouk, Naishu Kui, Ryan Sun, Jason R. Westin, Raphael E. Steiner, Ranjit Nair, Loretta J. Nastoupil, Luis E. Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins, Mansoor Noorani, Kaberi Das, Jared Henderson, Elizabeth J. Shpall, Partow Kebriaei, Jeremy Ramdial, Christopher R. Flowers, Sattva S. Neelapu, Sairah Ahmed, Paolo Strati
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Complications occurring after lymphodepleting chemotherapy (LDC) may delay chimeric antigen receptor (CAR) T-cell infusion. The effect of these delays on clinical outcomes is unclear. We performed a retrospective analysis of 240 patients with relapse
Externí odkaz:
https://doaj.org/article/b01259b6f4fa46b6872193b9823dd88d
Autor:
Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ethan B. Wang, BA, Sairah Ahmed, MD, Madeleine Duvic, MD, Preetesh Jain, MD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Paolo Strati, MD, Auris O. Huen, MD, PharmD, Swaminathan P. Iyer, MD, Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Jillian R. Gunther, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 6, Pp 101279- (2023)
Purpose: Purpose: Radiation therapy (RT) and the antibody-drug conjugate brentuximab vedotin (BV) are standard-of-care treatment options for patients with certain B and T-cell lymphomas; however, there are limited data exploring the safety of concurr
Externí odkaz:
https://doaj.org/article/d902d9f49c7047199b12871407803f0e
Autor:
Paolo Strati, Lei Feng, Jason Westin, Ranjit Nair, Sushanth Gouni, Luis Fayad, Maria Rodriguez, Dai Chihara, Luis Malpica, Raphael Steiner, Mariana Gallardo, Loretta J. Nastoupil, Sattva Neelapu
Publikováno v:
HemaSphere, Vol 7, p e6330214 (2023)
Externí odkaz:
https://doaj.org/article/07f72bc945224503956178db4ca6b20e
Autor:
Paolo Strati, Franck Morschhauser, Alexey Danilov, Chan Cheah, Harsh Shah, Wojciech Jurczak, Damilola Olabode, Stefanie Meyer, Jeong Lim Yoon, Serena Arduini, Jamal Saeh, Richardp Olsson, Gareth Gregory
Publikováno v:
HemaSphere, Vol 7, p e47925e9 (2023)
Externí odkaz:
https://doaj.org/article/04b648a35fa344c1886b10a714406dae